6 Results for "

ERAD

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "ERAD" in MCE Product Catalog:

16
16 Publications Verification
Cat. No.: HY-19332
CAS No.: 109944-15-2
Synonyms: FR-900494
Kifunensine, a potent and selective inhibitor of class I α-mannosidases isolated from Actinomycete, prevents α-mannosidases I from trimming mannose residues on glycoproteins. Kifunensine inhibits ERAD .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-110078
CAS No.: 412960-54-4
Pureté:  99.56%
Target:  

p97 Apoptosis

Domaines de recherche:  

Cancer

Eeyarestatin I, a potent endoplasmic reticulum-associated protein degradation (ERAD) inhibitor, is a potent protein translocation inhibitor. Eeyarestatin I inhibits Sec61 translocon. Eeyarestatin I targets the p97-associated deubiquitinating process (PAD) and inhibits atx3-dependent deubiquitination. Eeyarestatin I interferes at a step prior to proteasomal degradation. Eeyarestatin I induces cell death via the proapoptotic protein NOXA and has anticancer effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-49116
CAS No.: 500285-30-3
Target:  

E1/E2/E3 Enzyme

Domaines de recherche:  

Infection Inflammation/Immunology

CP26 is a small molecule inhibitor of protein dislocation from the ER lumen to the cytosol. CP26 targets the Hrd1 complex, inhibits ERAD, and induces ER stress .
loading...
    loading...
Cat. No.: HY-19332R
CAS No.: 109944-15-2
Synonyms: FR-900494 (Standard)
Bromperidol decanoate (Standard) is the analytical standard of Bromperidol decanoate. This product is intended for research and analytical applications. Bromperidol decanoate (R46541) is a compound used for the inhibition of schizophrenia and has certain clinical inhibitory activity.
loading...
    loading...
Cat. No.: HY-167673
CAS No.: 1807639-36-6
Target:  

E1/E2/E3 Enzyme

Domaines de recherche:  

Infection Inflammation/Immunology Cancer

RNF5-IN-1 (FX12) is a selective RNF5 degrader. RNF5-IN-1 binds to RNF5 and inhibits its E3 activity, and promotes proteasomal degradation of RNF5 in an endoplasmic reticulum (ER)-associated degradation (ERAD) way in cells. RNF5-IN-1 inhibits α-1-antitrypsin (NHK) dislocation with an IC50 value of 2.7 μM. RNF5-IN-1 can be used for research of cystic fibrosis, acute myeloid leukemia, and certain viral infections .
loading...
    loading...
Cat. No.: HY-181529
CAS No.: 1212623-02-3
Target:  

VDAC PERK

Domaines de recherche:  

Cancer

NCATS-SM0225 is an endoplasmic reticulum-associated degradation (ERAD) inhibitor and a direct binder of VDAC1, VDAC2 and VDAC3. NCATS-SM0225 exhibits an IC50of 1.02 μM for ERAD and a Kd of 3.13 μM for human VDAC1 binding. NCATS-SM0225 disrupts cellular calcium homeostasis, enhances VDAC1-IP3R coupling and activating PERK. NCATS-SM0225 selectively kills cancer cells, exhibits tumor growth inhibitory effects in melanoma xenograft models. NCATS-SM0225 can be used for research on multiple cancers including melanoma, as well as the molecular mechanisms of ERAD and calcium homeostasis regulation .
loading...
    loading...